scholarly journals The micro RNA hsa-miR-377-3p inhibits tumor growth in malignant melanoma

RSC Advances ◽  
2019 ◽  
Vol 9 (33) ◽  
pp. 19057-19064
Author(s):  
Jian Yuan ◽  
Lei Jiang ◽  
Chaotang Guo

We have demonstrated that miR-377-3p inhibits melanoma cell growth by binding to the ARMC8 mRNA in the A375 cell line.

2020 ◽  
Vol 15 (3) ◽  
pp. 1934578X2091286
Author(s):  
Fan Yang ◽  
Yin-hui Yang ◽  
Wei-hui Zeng

Malignant melanoma is one of the most aggressive skin cancers, having a very high mortality rate. However, its effective treatment is not clear. Ampelopsin, a plant flavonoid, has been reported to inhibit cell growth and/or induce apoptosis in various types of tumor. In this study, it was shown that ampelopsin significantly inhibits melanoma A375 cell line proliferation in a concentration-dependent/time-dependent manner. The flow cytometric data clearly demonstrated that ampelopsin causes cell cycle arrest in the G2/M phase. Moreover, it also confirmed that growth inhibition mediated by treatment with ampelopsin is related to the decreased expression of Cdc2, Cdc25c, cyclin B1, and activation of caspase-3 and Bax, purportedly by epidermal growth factor receptor (EGFR), extracellular regulated protein kinases, and matrix metalloproteinase-2 (MMP-2) downregulation. As a result of this work, these findings suggest that ampelopsin inhibits human malignant melanoma A375 cell line proliferation by suppressing the EGFR/ERK/MMP-2 pathway.


2001 ◽  
Vol 134 (6) ◽  
pp. 1215-1226 ◽  
Author(s):  
Stefania Merighi ◽  
Katia Varani ◽  
Stefania Gessi ◽  
Elena Cattabriga ◽  
Valeria Iannotta ◽  
...  

2022 ◽  
pp. 100539
Author(s):  
Alex Laux ◽  
Josias Hamman ◽  
Hanna Svitina ◽  
Krzysztof Wrzesinski ◽  
Chrisna Gouws

Author(s):  
Qin Shen ◽  
Fen Tian ◽  
Ping Jiang ◽  
Yanqiu Li ◽  
Li Zhang ◽  
...  

2020 ◽  
Vol 21 (18) ◽  
pp. 6706
Author(s):  
Geon-Hee Kim ◽  
Xue-Quan Fang ◽  
Woo-Jin Lim ◽  
Jooho Park ◽  
Tae-Bong Kang ◽  
...  

Constitutive activation of the β-catenin dependent canonical Wnt signaling pathway, which enhances tumor growth and progression in multiple types of cancer, is commonly observed in melanoma. LEF1 activates β-catenin/TCF4 transcriptional activity, promoting tumor growth and progression. Although several reports have shown that LEF1 is highly expressed in melanoma, the functional role of LEF1 in melanoma growth is not fully understood. While A375, A2058, and G361 melanoma cells exhibit abnormally high LEF1 expression, lung cancer cells express lower LEF1 levels. A luciferase assay-based high throughput screening (HTS) with a natural compound library showed that cinobufagin suppressed β-catenin/TCF4 transcriptional activity by inhibiting LEF1 expression. Cinobufagin decreases LEF1 expression in a dose-dependent manner and Wnt/β-catenin target genes such as Axin-2, cyclin D1, and c-Myc in melanoma cell lines. Cinobufagin sensitively attenuates cell viability and induces apoptosis in LEF1 expressing melanoma cells compared to LEF1-low expressing lung cancer cells. In addition, ectopic LEF1 expression is sufficient to attenuate cinobufagin-induced apoptosis and cell growth retardation in melanoma cells. Thus, we suggest that cinobufagin is a potential anti-melanoma drug that suppresses tumor-promoting Wnt/β-catenin signaling via LEF1 inhibition.


2007 ◽  
Vol 16 (11) ◽  
pp. 899-904 ◽  
Author(s):  
Juan Tao ◽  
Ye-qiang Liu ◽  
Yan Li ◽  
Ji-ling Peng ◽  
Li Li ◽  
...  

Nature ◽  
1984 ◽  
Vol 311 (5987) ◽  
pp. 671-673 ◽  
Author(s):  
R. A. Padua ◽  
N. Barrass ◽  
G. A. Currie

Sign in / Sign up

Export Citation Format

Share Document